Rising prices, especially for prescription drugs, surgery, and emergency department visits, caused overall healthcare spending in 2016 to grow faster than at any time in the last 5 years; however, Americans used the same amount or less healthcare in 2016 compared with 2015, according to a report by the Health Care Cost Institute.
Rising prices, especially for prescription drugs, surgery, and emergency department (ED) visits, caused overall healthcare spending in 2016 to grow faster than at any time in the last 5 years, according to the Health Care Cost Institute (HCCI). However, Americans used the same amount or less healthcare in 2016 compared with 2015, according to the HCCI’s annual Health Care Cost and Utilization Report, which analyzed healthcare spending and utilization from 2012 to 2016 for people up to age 65 with employer-sponsored health insurance.
Four major health insurers contributed data to HCCI for the purposes of producing a national, multi-payer, commercial healthcare claims database: Aetna, Humana, Kaiser Permanente, and UnitedHealthcare.
“It is time to have a national conversation on the role of price increases in the growth of healthcare spending,” Niall Brennan, MPP, president of HCCI, said in a statement. “Despite the progress made in recent years on value-based care, the reality is that working Americans are using less care but paying more for it every year. Rising prices, especially for prescription drugs, surgery, and emergency department visits, have been primary drivers of faster growth in recent years.
Prescription drug spending had cumulative growth of 27%, despite a flat or decreasing trend in generic drug prices and despite a fall in utilization of brand prescription drugs. During the study period, the price of brand prescription drugs soared by double digits, which drove drug spending higher.
Three classes of drugs were behind the rise in prescription drug spending, the report found:
While the number of ED visits rose just slightly, the average price per visit grew steadily over the 5-year study for a 31.5% cumulative increase, driving the increase in outpatient spending.
The average price of surgery rose as well, pushing up spending for both inpatient and outpatient care. The average price for surgical admissions increased by nearly $10,000 or 30%, despite a -16% cumulative decline in utilization. The price for outpatient surgery rose more than 19%.
The study also reported:
“While consumers, especially those with employer-sponsored insurance, may not feel the direct impact of these charges via OOP payments, they ultimately pay through increased premiums and decreased benefits,” said Brennan.
HCCI is an independent, nonpartisan research organization that analyzes the causes of the rise in health spending.
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More